Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
By C. Kang, Sung‐Han Kim, Hong-Bin Kim, Sang-Won Park, Y. Choe, M. Oh, E. Kim, K. Choe. Clinical Infectious Diseases, 2003
607 citations recorded by the source corpus.
Subfields: Clinical Biochemistry, Critical Care and Intensive Care Medicine, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/74174c94dbb8beb8b04b316f72cf2c7d5234b91e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Biochemistry
In Critical Care and Intensive Care Medicine
In Molecular Medicine
Citations in the corpus
- Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome (2004, background): “Appropriate antimicrobial therapy has been shown to reduce mortality among patients with gram-negative bacteremia (10, 15) and, when initiated early, to have a favorable effect on outcome in critically ill patients with bacteremia or other serious infections (5–7, 10, 16–18, 23).”
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria (2012, background): “Although the need for definitive combination therapy is questionable, delays in initiating appropriate antimicrobial therapy for pseudomonal infections (which often consists of combination therapy) have been associated with higher mortality (27, 117, 123, 124, 157, 165, 166).”
- Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. (2008, background): “Inadequate frontline antimicrobial treatment has long been recognized as an independent determinant of hospital mortality among patients with cancer who develop severe bacterial infections [13, 14].”
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* (2006, background): “In serious human infections, rapidity of antimicrobial therapy following presentation has been understood to be a critical determinant of outcome for specific conditions including community-acquired pneumonia (7, 9, 14, 17), ventilator-associated pneumonia (11), meningitis (10, 13), bacteremia (14, ”